Focused on robot-assisted dental surgery technology, Neocis develops precision healthcare robotics. Principals of the firm work closely with dental surgeons to understand their specific needs enabling the development of robotic technology that is capable of overcoming surgical and treatment challenges. Neocis was founded by two engineers with prior experience in robotic surgery from their time at Mako Surgical, where they were two of the first principal engineers to develop the revolutionary RIO system for robotic guided orthopedics. After Mako had a successful IPO and ultimately sold to Stryker for $1.65B, these two engineers sought another medical market that would fit the sort of robotic surgery technology they had spent years developing, eventually settling on dental surgery. After securing several rounds of funding beginning in 2012, the firm's Yomi robotic dental surgery product completed a successful clinical study in 2016. Yomi is the first and only robot-assisted dental surgery system to be commercially available in the United States and is in clinical use with leading dental surgeons.
